268 related articles for article (PubMed ID: 16154121)
1. Biochemical evaluation of the inflammatory changes in cardiac, hepatic and renal tissues of adriamycin-administered rats and the modulatory role of exogenous heparin-derivative treatment.
Deepa PR; Varalakshmi P
Chem Biol Interact; 2005 Oct; 156(2-3):93-100. PubMed ID: 16154121
[TBL] [Abstract][Full Text] [Related]
2. Influence of a low-molecular-weight heparin derivative on the nitric oxide levels and apoptotic DNA damage in adriamycin-induced cardiac and renal toxicity.
Deepa PR; Varalakshmi P
Toxicology; 2006 Jan; 217(2-3):176-83. PubMed ID: 16242830
[TBL] [Abstract][Full Text] [Related]
3. Favourable modulation of the inflammatory changes in hypercholesterolemic atherogenesis by a low-molecular-weight heparin derivative.
Deepa PR; Varalakshmi P
Int J Cardiol; 2006 Jan; 106(3):338-47. PubMed ID: 16337042
[TBL] [Abstract][Full Text] [Related]
4. Beneficial cardio-renovascular effects of a low-molecular-weight heparin-derivative on adriamycin-induced glycosaminoglycanuria and tissue lipid abnormalities.
Deepa PR; Varalakshmi P
Toxicology; 2005 Jul; 211(1-2):77-85. PubMed ID: 15863250
[TBL] [Abstract][Full Text] [Related]
5. Protective effect of low molecular weight heparin on oxidative injury and cellular abnormalities in adriamycin-induced cardiac and hepatic toxicity.
Deepa PR; Varalakshmi P
Chem Biol Interact; 2003 Oct; 146(2):201-10. PubMed ID: 14597133
[TBL] [Abstract][Full Text] [Related]
6. Protective effect of lycopene on adriamycin-induced cardiotoxicity and nephrotoxicity.
Yilmaz S; Atessahin A; Sahna E; Karahan I; Ozer S
Toxicology; 2006 Feb; 218(2-3):164-71. PubMed ID: 16325981
[TBL] [Abstract][Full Text] [Related]
7. Atheroprotective effect of exogenous heparin-derivative treatment on the aortic disturbances and lipoprotein oxidation in hypercholesterolemic diet fed rats.
Deepa PR; Varalakshmi P
Clin Chim Acta; 2005 May; 355(1-2):119-30. PubMed ID: 15820486
[TBL] [Abstract][Full Text] [Related]
8. Silymarin prevents adriamycin-induced cardiotoxicity and nephrotoxicity in rats.
El-Shitany NA; El-Haggar S; El-desoky K
Food Chem Toxicol; 2008 Jul; 46(7):2422-8. PubMed ID: 18487002
[TBL] [Abstract][Full Text] [Related]
9. Melatonin controls oxidative stress and modulates iron, ferritin, and transferrin levels in adriamycin treated rats.
Othman AI; El-Missiry MA; Amer MA; Arafa M
Life Sci; 2008 Oct; 83(15-16):563-8. PubMed ID: 18793653
[TBL] [Abstract][Full Text] [Related]
10. Amelioration of doxorubicin-induced cardiac and renal toxicity by pirfenidone in rats.
Giri SN; Al-Bayati MA; Du X; Schelegle E; Mohr FC; Margolin SB
Cancer Chemother Pharmacol; 2004 Feb; 53(2):141-50. PubMed ID: 14564477
[TBL] [Abstract][Full Text] [Related]
11. The efficacy of selenium, WR-2721, and their combination in the prevention of adriamycin-induced cardiotoxicity in rats.
Dobrić S; Dragojević-Simić V; Bokonjić D; Milovanović S; Marincić D; Jović P
J Environ Pathol Toxicol Oncol; 1998; 17(3-4):291-9. PubMed ID: 9726805
[TBL] [Abstract][Full Text] [Related]
12. Favourable influence of low molecular weight heparin in mitigating the peroxidative membrane damage induced by a cytotoxic agent and an atherogenic diet.
Deepa PR; Varalakshmi P
Hum Exp Toxicol; 2003 May; 22(5):229-35. PubMed ID: 12774884
[TBL] [Abstract][Full Text] [Related]
13. Protective role of granulocyte colony-stimulating factor against adriamycin induced cardiac, renal and hepatic toxicities.
Hou XW; Jiang Y; Wang LF; Xu HY; Lin HM; He XY; He JJ; Zhang S
Toxicol Lett; 2009 May; 187(1):40-4. PubMed ID: 19429242
[TBL] [Abstract][Full Text] [Related]
14. [Relationship between glomerular nephrin expression and oxidative stress reaction in rats with adriamycin-induced nephrosis].
Zhu Y; Lu L
Zhongguo Dang Dai Er Ke Za Zhi; 2009 Jan; 11(1):56-60. PubMed ID: 19149925
[TBL] [Abstract][Full Text] [Related]
15. Salubrious effects of lipoic acid against adriamycin-induced clastogenesis and apoptosis in Wistar rat bone marrow cells.
Prahalathan C; Selvakumar E; Varalakshmi P; Kumarasamy P; Saravanan R
Toxicology; 2006 May; 222(3):225-32. PubMed ID: 16580770
[TBL] [Abstract][Full Text] [Related]
16. Low molecular weight heparin protection against oxalate-induced oxidative renal insult.
Rajeswari A; Varalakshmi P
Clin Chim Acta; 2006 Aug; 370(1-2):108-14. PubMed ID: 16516183
[TBL] [Abstract][Full Text] [Related]
17. Lipoic acid modulates adriamycin-induced testicular toxicity.
Prahalathan C; Selvakumar E; Varalakshmi P
Reprod Toxicol; 2006 Jan; 21(1):54-9. PubMed ID: 16112542
[TBL] [Abstract][Full Text] [Related]
18. Oral selenium supplementation in rats reduces cardiac toxicity of adriamycin during ischemia and reperfusion.
Boucher F; Coudray C; Tirard V; Barandier C; Tresallet N; Favier A; de Leiris J
Nutrition; 1995; 11(5 Suppl):708-11. PubMed ID: 8748259
[TBL] [Abstract][Full Text] [Related]
19. The protective effect of melatonin on adriamycin-induced acute cardiac injury.
Koçak G; Erbil KM; Ozdemir I; Aydemir S; Sunar B; Tuncel M; Atalay S
Can J Cardiol; 2003 Apr; 19(5):535-41. PubMed ID: 12717489
[TBL] [Abstract][Full Text] [Related]
20. Protective effects of certoparin sodium, a low molecular weight heparin derivative, in experimental atherosclerosis.
Deepa PR; Varalakshmi P
Clin Chim Acta; 2004 Jan; 339(1-2):105-15. PubMed ID: 14687900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
